Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-02-22 @ 11:40 PM
Study NCT ID:
NCT02733068
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2016-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Sponsor:
Shanghai Zerun Biotechnology Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-02
Start Date Type:
None
Primary Completion Date:
2019-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-01-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-19
First Submit QC Date:
None
Study First Post Date:
2016-04-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-16
Last Update Post Date:
2022-12-19
Last Update Post Date Type:
ACTUAL